<< Back To Search

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Notify the Multiple Myeloma Research Foundation you are interested in this trial
NCT05552976
Age 18 +
Sex Both
Phase Phase 3
Third Opinion Trial Synopsis
This study is comparing two different medicine treatments for people with RRMM. One treatment uses a medicine called CC-92480 and the other treatment uses a medicine called carfilzomib and dexamethasone. The goal is to see which treatment works better.
Third Opinion AI Generated Synopsis

Trial Summary
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of RRMM: SUCCESSOR-2.
from ClinicalTrials.gov

Locations & Contact

Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?

Contacts: